MYLAN 6150 MYLAN 6150 (Omeprazole 20 mg)
Pill imprint MYLAN 6150 MYLAN 6150 has been identified as Omeprazole 20 mg.
Omeprazole is used in the treatment of gerd; barrett's esophagus; erosive esophagitis; gastritis/duodenitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy. Omeprazole 20 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 20 mg
- 18.00 mm
- Rx and/or OTC
D&C Yellow No. 10
FD&C Green No. 3
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0007||UDL Laboratories Inc|
|55887-0396||Diversified Healthcare Services Inc (repackager)|
Note: Inactive ingredients may vary.
More about omeprazole
- Omeprazole delayed-release capsules
- Omeprazole delayed-release oral suspension
- Omeprazole delayed-release tablets
- Omeprazole magnesium delayed-release capsules and tablets
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.